المؤلفون: Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK., Nabilah A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK., Murali M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK., Peng Z; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK., Merx J; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, 6525 XZ Nijmegen, The Netherlands., Rossing E; GlycoTherapeutics B.V., 6511 AJ Nijmegen, The Netherlands., Pijnenborg JFA; GlycoTherapeutics B.V., 6511 AJ Nijmegen, The Netherlands., Boltje TJ; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, 6525 XZ Nijmegen, The Netherlands.; GlycoTherapeutics B.V., 6511 AJ Nijmegen, The Netherlands., Wang N; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield S10 2TN, UK.; Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Leicester LE2 7LX, UK., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle NE1 3BZ, UK.

المصدر: Cancers [Cancers (Basel)] 2024 Aug 24; Vol. 16 (17). Date of Electronic Publication: 2024 Aug 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Fisher M; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Beatson R; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London (UCL), Rayne 9 Building, London WC1E 6JF, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK., Livermore K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Zhou Y; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Newcastle upon Tyne NE2 4HH, UK., Visser EA; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands., Pijnenborg JF; GlycoTherapeutics B.V., Nijmegen, the Netherlands., Eerden N; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands; GlycoTherapeutics B.V., Nijmegen, the Netherlands., Moons SJ; Synvenio B.V., Nijmegen, the Netherlands., Rossing E; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Krishna R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Peng Z; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Nangkana KP; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Schmidt EN; Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK; International Centre for Life, Biosciences Institute, Newcastle University, Newcastle Upon Tyne NE1 3BZ, UK., Dennis EP; International Centre for Life, Biosciences Institute, Newcastle University, Newcastle Upon Tyne NE1 3BZ, UK., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Newcastle upon Tyne NE2 4HH, UK; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK., Lawson MA; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK., Macauley M; Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Büll C; Biomolecular Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, the Netherlands., Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Boltje TJ; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands., Drake RR; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK; Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, LE2 7LX, UK. Electronic address: nw208@Leicester.ac.uk., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK. Electronic address: Jennifer.munkley@ncl.ac.uk.

المصدر: EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105163. Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/drug therapy , Sialyltransferases*/metabolism , Sialyltransferases*/genetics , Bone Neoplasms*/secondary , Bone Neoplasms*/metabolism , Bone Neoplasms*/drug therapy , N-Acetylneuraminic Acid*/metabolism, Male ; Humans ; Animals ; Mice ; Cell Line, Tumor ; Disease Models, Animal ; Antigens, CD/metabolism ; Polysaccharides/pharmacology ; Glycosylation ; beta-D-Galactoside alpha 2-6-Sialyltransferase

المؤلفون: Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Central Parkway, Newcastle-upon-Tyne, Tyne and Wear NE1 3BZ, United Kingdom., Visser EA; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Central Parkway, Newcastle-upon-Tyne, Tyne and Wear NE1 3BZ, United Kingdom., Hipgrave Ederveen AL; Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Bastian K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Central Parkway, Newcastle-upon-Tyne, Tyne and Wear NE1 3BZ, United Kingdom., Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Central Parkway, Newcastle-upon-Tyne, Tyne and Wear NE1 3BZ, United Kingdom., Öztürk Ö; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands., Pijnenborg JFA; GlycoTherapeutics B.V., Toernooiveld 1, 6525 ED Nijmegen, The Netherlands., Eerden N; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.; GlycoTherapeutics B.V., Toernooiveld 1, 6525 ED Nijmegen, The Netherlands., Moons SJ; Synvenio B.V., Toernooiveld 1, 6525 ED Nijmegen, The Netherlands., Rossing E; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands., Wang N; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Medical School, Beech Hill Rd, Sheffield, Yorkshire S10 2RX, United Kingdom., de Haan N; Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Büll C; Biomolecular Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands., Boltje TJ; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Central Parkway, Newcastle-upon-Tyne, Tyne and Wear NE1 3BZ, United Kingdom.

المصدر: Glycobiology [Glycobiology] 2023 Dec 30; Vol. 33 (12), pp. 1155-1171.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9104124 Publication Model: Print Cited Medium: Internet ISSN: 1460-2423 (Electronic) Linking ISSN: 09596658 NLM ISO Abbreviation: Glycobiology Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/metabolism, Male ; Humans ; Glycosylation ; Protein Processing, Post-Translational ; Polysaccharides/metabolism

المؤلفون: Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Calle B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK., Cheung K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bermudez A; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Marques FJG; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Pye H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Yo EC; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Islam K; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland., Oo HZ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., McClurg UL; Institute for Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Thomas H; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bastian K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Arredondo HM; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Roustan C; Structural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT, London, UK., Gray MA; Sarafan Chem-H and Departemnt of Chemistry, Stanford University, 424 Santa Teresa St, Stanford, CA, 94305, USA., Kelly L; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Tolson A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Mellor E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Haider A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Singh S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Johnston EW; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Punwani S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Knight B; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McCullagh P; Department of Pathology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McGrath J; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Crundwell M; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Harries L; Institute of Biomedical and Clinical Sciences, Medical School, College of Medicine and Health, University of Exeter, Exeter, UK., Bogdan D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Westaby D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Fowler G; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Flohr P; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Yuan W; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Sharp A; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., de Bono J; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Wisnovsky S; University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, BC, V6T 1Z3, Canada., Bertozzi CR; Howard Hughes Medical Institute, 424 Santa Teresa St, Stanford, CA, 94305, USA., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, UK., Guerrero RH; University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza, Spain; Fundación ARAID, 50018, Zaragoza, Spain.; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Leivo J; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Whitaker H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Pitteri S; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Schumann B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK. Jennifer.munkley@ncl.ac.uk.

المصدر: Oncogene [Oncogene] 2023 Mar; Vol. 42 (12), pp. 926-937. Date of Electronic Publication: 2023 Feb 01.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/metabolism, Male ; Humans ; Up-Regulation ; Glycosylation ; Signal Transduction ; Transcriptional Activation

المؤلفون: McClements ME; Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, and Oxford University Hospitals NHS Foundation Trust, NIHR Biomedical Research Centre, Oxford, UK., Steward H; Newcells Biotech Limited, Newcastle upon Tyne, UK., Atkin W; Newcells Biotech Limited, Newcastle upon Tyne, UK., Goode EA; Newcells Biotech Limited, Newcastle upon Tyne, UK., Gándara C; Newcells Biotech Limited, Newcastle upon Tyne, UK., Chichagova V; Newcells Biotech Limited, Newcastle upon Tyne, UK., MacLaren RE; Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, and Oxford University Hospitals NHS Foundation Trust, NIHR Biomedical Research Centre, Oxford, UK.

المصدر: Translational vision science & technology [Transl Vis Sci Technol] 2022 Apr 01; Vol. 11 (4), pp. 3.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Association for Research in Vision and Ophthalmology Country of Publication: United States NLM ID: 101595919 Publication Model: Print Cited Medium: Internet ISSN: 2164-2591 (Electronic) Linking ISSN: 21642591 NLM ISO Abbreviation: Transl Vis Sci Technol Subsets: MEDLINE

مواضيع طبية MeSH: Induced Pluripotent Stem Cells* , Organoids*, Dependovirus/genetics ; Genetic Vectors/genetics ; Humans ; Retina ; Transduction, Genetic ; Tropism

المؤلفون: Nagarajan S; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Rao SV; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Sutton J; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Cheeseman D; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Dunn S; Wellcome Trust Sanger Institute, Hinxton, UK., Papachristou EK; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Prada JG; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Couturier DL; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Kumar S; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Kishore K; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Chilamakuri CSR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Glont SE; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Goode EA; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Brodie C; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Natrajan R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Bruna A; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Caldas C; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Russell A; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Siersbæk R; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Yusa K; Wellcome Trust Sanger Institute, Hinxton, UK.; Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan., Chernukhin I; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Carroll JS; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. Jason.carroll@cruk.cam.ac.uk.

المصدر: Nature genetics [Nat Genet] 2020 Mar; Vol. 52 (3), pp. 354.

نوع المنشور: Journal Article; Published Erratum

بيانات الدورية: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: PubMed not MEDLINE; MEDLINE